Skip to main content
. 2017 Aug 14;8(50):87221–87233. doi: 10.18632/oncotarget.20250

Figure 2. Kaplan Meier survival curve demonstrating KRAS mutation (dotted line) significantly associates with a poorer disease specific survival vs KRAS wild type (solid line) when detected in cfDNA of PDAC patients (p=0. 018).

Figure 2